Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Choice, transparency, coordination, and quality among direct-to-consumer telemedicine websites and apps treating skin disease.

Resneck JS, Abrouk M, Steuer M, et al. Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps Treating Skin Disease. JAMA Dermatol. 2016;152(7):768-75. doi:10.1001/jamadermatol.2016.1774.

Save
Print
June 1, 2016
Resneck JS, Abrouk M, Steuer M, et al. JAMA Dermatol. 2016;152(7):768-75.
View more articles from the same authors.

Telemedicine is being more widely used in order to increase access to care. A relatively new aspect of telemedicine is direct-to-consumer telemedicine, including teledermatology. Using secret shoppers who submitted photographs and clinical information to teledermatology sites, this study found poor diagnostic accuracy and failure to elicit important information. Other studies have also raised concerns about the diagnostic accuracy of virtual clinical visits.

Save
Print
Cite
Citation

Resneck JS, Abrouk M, Steuer M, et al. Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps Treating Skin Disease. JAMA Dermatol. 2016;152(7):768-75. doi:10.1001/jamadermatol.2016.1774.

Related Resources From the Same Author(s)
Related Resources